Neurology® Clinical Practice Podcast

Alert: There is an updated RSS feed for Neurology® Clinical Practice: http://www.aan.com/rss/index.cfm?event=feed.items&channel=1. The Neurology journals have combined all feeds into a central location to better serve subscribers. Neurology® Clinical Practice, an official journal of the American Academy of Neurology, brings the neurologist timely updates of peer-reviewed clinical neurology material, along with helpful analyses of office-based and health policy issues.

http://www.aan.com/rss/?event=feed&channel=22

subscribe
share






April 2015 Issue


John Corboy, Editor of Neurology: Clinical Practice introduces highlights from the April 2015 issue. In the first interview segment, Dr. Corboy interviews Drs. Omar Khan and Lilyana Amezcua about their paper titled "Multiple sclerosis in US minority populations: Clinical practice insights." In the second interview segment, Dr. Corboy interviews Dr. Jack Tsao about his paper titled "Recent advances in bioelectric prostheses."

J. Corboy served as a Section Editor for Neurology Today and serves as editor of Neurology: Clinical Practice; serves on the speakers' bureau for ProCE; receives/received research support from Genentech, Novartis, Biogen IDEC, Teva, Eli Lilly, Orasi Medical, NIH, Juvenile Diabetes Research Foundation, and National MS Society; and has participated in medico-legal cases.

O. Khan serves on scientific advisory boards for Teva Pharmaceuticals, Biogen Idec, National MS Society, and Genentech/Roche; has received funding for travel or speaker honoraria from Teva Pharmaceuticals, Novartis, and Biogen Idec; serves on the editorial board of the Journal of Neurological Sciences; serves as a consultant for Teva Pharmaceuticals, Novartis, Biogen Idec, EMD Serono, Roche, Genzyme, and Questcor; serves on speakers' bureaus for Teva Pharmaceuticals, Novartis, and Biogen Idec; receives research support from Teva Pharmaceuticals, Novartis, Biogen Idec, Genzyme, Roche, NIH, National MS Society, DMC Foundation, and Sastry Foundation.

L. Amezcua serves on scientific advisory boards for Biogen Idec, Novartis, and Acorda; has received funding for travel or speaker honoraria from Biogen, Novartis, Genzyme, and Acorda; serves/has served as a consultant for Biogen Idec, TEVA, Genzyme, Questcor, Novartis, and Acorda.

J. Tsao receives publishing royalties for Traumatic Brain Injury: A Clinician's Guide to Diagnosis, Management, and Rehabilitation (Springer, 2012); and has received funding from the US Army Medical Research and Materiel Command and the Wounded, Ill & Injured Directorate, US Navy Bureau of Medicine and Surgery to support research on the modular prosthetic limb described in this report.


fyyd: Podcast Search Engine
share








 April 13, 2015  31m